35 related articles for article (PubMed ID: 2336558)
21. Acute myeloblastic leukemia in pregnancy: a case report and review of the literature.
Yucebilgin MS; Cagirgan S; Donmez A; Ozkinay E; Akercan F; Mgoyi L; Vural F
Eur J Gynaecol Oncol; 2004; 25(1):126-8. PubMed ID: 15053082
[TBL] [Abstract][Full Text] [Related]
22. Idarubicin including regimens in acute myelogenous leukemia in elderly patients.
Leone G; Sica S; Pagano L
Crit Rev Oncol Hematol; 1999 Sep; 32(1):59-68. PubMed ID: 10586356
[No Abstract] [Full Text] [Related]
23. Acute myelogenous leukemia in an adult with thrombocytopenia with absent radii syndrome.
Go RS; Johnston KL
Eur J Haematol; 2003 Apr; 70(4):246-8. PubMed ID: 12656750
[TBL] [Abstract][Full Text] [Related]
24. Myelomastocytic leukemia with aberrant CD25 expression: case report and review of the literature.
Rich A; Sun J; Aldayel AS; Yin CC; Medeiros LJ; Konoplev S
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):e173-7. PubMed ID: 25022599
[No Abstract] [Full Text] [Related]
25. [Acute myeloid leukemia with poor prognosis: treatment with oral 4-demethoxydaunorubicin (idarubicin) and low-dose cytarabine via subcutaneous route].
Helg C; Chapuis B; Grob JP; Pugin P
Schweiz Med Wochenschr; 1990 Apr; 120(15):548-52. PubMed ID: 2336558
[TBL] [Abstract][Full Text] [Related]
26. [Acute myelogenous leukemia developed at the 26th week of gestation].
Tashiro H; Umezawa K; Shirota M; Oka Y; Shirasaki R; Nishi R; Taguchi A; Akiyama N; Kawasugi K; Ayabe T; Shirafuji N
Rinsho Ketsueki; 2011 Jan; 52(1):18-22. PubMed ID: 21378477
[TBL] [Abstract][Full Text] [Related]
27. Idarubicin: an anthracycline antineoplastic agent.
Cersosimo RJ
Clin Pharm; 1992 Feb; 11(2):152-67. PubMed ID: 1551297
[TBL] [Abstract][Full Text] [Related]
28. Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991.
Keating MJ; Estey E; Kantarjian H; Plunkett W; O'Brien S; Koller C; Beran M; Freireich EJ
Leukemia; 1992; 6 Suppl 2():78-80. PubMed ID: 1578950
[No Abstract] [Full Text] [Related]
29. Attenuated-dose idarubicin in acute myeloid leukaemia of the elderly: pharmacokinetic study and clinical results.
Leoni F; Ciolli S; Giuliani G; Pascarella A; Caporale R; Salti F; Cervi L; Rossi Ferrini P
Br J Haematol; 1995 May; 90(1):169-74. PubMed ID: 7786781
[TBL] [Abstract][Full Text] [Related]
30. Idarubicin: a second-generation anthracycline.
Fields SM; Koeller JM
DICP; 1991 May; 25(5):505-17. PubMed ID: 2068836
[TBL] [Abstract][Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
